Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea · Delayed Price · Currency is KRW

73,700

+2,000 (2.79%)

Last updated: Jun 16, 2026, 2:03 PM KST

-13.80% (1Y)

Market Cap	973.71B -7.0%
Revenue (ttm)	1.74T +7.0%
Net Income	78.55B -17.6%
EPS	5,923.89 -17.8%
Shares Out	13.18M
PE Ratio	12.47
Forward PE	14.94
Dividend	1,100.00 (1.53%)
Ex-Dividend Date	Dec 29, 2025

Volume	22,848
Open	72,800
Previous Close	71,700
Day's Range	72,400 - 74,000
52-Week Range	67,900 - 106,800
Beta	0.24
Analysts	Buy
Price Target	119,166.67 (+61.69%)
Earnings Date	Jul 27, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1941

Employees 2,253

Stock Exchange Korea Stock Exchange

Ticker Symbol 185750

Full Company Profile

Financial Performance

In 2025, KRX:185750's revenue was 1.69 trillion, an increase of 6.68% compared to the previous year's 1.59 trillion. Earnings were 77.51 billion, a decrease of -28.94%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 185750 stock is "Buy." The 12-month stock price target is ₩119,167, which is an increase of 61.69% from the latest price.

Price Target

₩119,167

(61.69% upside)

Analyst Consensus: Buy

Stock Forecasts